Login / Signup

A randomized, open-label, two-period crossover bridging study on fuzuloparib capsules of different specifications in healthy Chinese volunteers.

Xin JiangYe TaoYanping LiuPing ShiTing LiFeifei SunYu CaoChenjing Wang
Published in: British journal of clinical pharmacology (2021)
The test preparations were bioequivalent to the reference preparations. All investigational products were well tolerated.
Keyphrases
  • open label
  • phase ii
  • clinical trial
  • phase ii study
  • study protocol
  • radiation therapy
  • double blind
  • placebo controlled